1859 Inc. Launches with $40 Million Collection A to Industrialize New Medicine Discovery by Combining Artificial Intelligence and Empirical Screening Knowledge at Scale
SAN DIEGO–(Business WIRE)–1859, Inc., a platform firm combining artificial intelligence and empirical pico-scale screening info at scale to find out new small molecule medications for emerging disease targets, launched right…